Edition:
United States

Anavex Life Sciences Corp (AVXL.OQ)

AVXL.OQ on NASDAQ Stock Exchange Capital Market

3.15USD
11:22am EDT
Change (% chg)

$0.03 (+0.96%)
Prev Close
$3.12
Open
$3.11
Day's High
$3.30
Day's Low
$3.11
Volume
40,410
Avg. Vol
125,195
52-wk High
$5.19
52-wk Low
$1.86

Chart for

About

Anavex Life Sciences Corp. is a clinical-stage biopharmaceutical company. The Company is engaged in the development of differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases, including drug candidates to treat Alzheimer's disease (AD), other central nervous system (CNS) diseases, pain... (more)

Overall

Beta: 1.23
Market Cap(Mil.): $137.55
Shares Outstanding(Mil.): 44.66
Dividend: --
Yield (%): --

Financials

  AVXL.OQ Industry Sector
P/E (TTM): -- 212.74 32.86
EPS (TTM): -0.41 -- --
ROI: -79.95 -3.73 13.13
ROE: -79.95 -5.79 15.07

BRIEF-Anavex Life Sciences Reports Q2 Loss Per Share Of $0.11

* ANAVEX LIFE SCIENCES REPORTS FISCAL SECOND QUARTER 2018 FINANCIAL RESULTS

May 10 2018

BRIEF-Anavex Life Sciences To Initiate Phase 2 Study Of Anavex®2-73 In Parkinson’S Disease Dementia

* ANAVEX LIFE SCIENCES TO INITIATE PHASE 2 STUDY OF ANAVEX®2-73 IN PARKINSON’S DISEASE DEMENTIA AND PROVIDES CLINICAL STUDY UPDATE FOR ANAVEX®2-73 IN RETT SYNDROME

Apr 17 2018

Earnings vs. Estimates